These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11365782)

  • 21. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of maintenance CMV therapy in HAART responders.
    Dunn JP
    Hopkins HIV Rep; 1999 May; 11(3):5. PubMed ID: 11367373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of a prospective trial to detect cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Uphold CR; Smith MF; Bender BS
    AIDS Patient Care STDS; 1998 Dec; 12(12):907-12. PubMed ID: 11362061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.
    Deayton JR; Wilson P; Sabin CA; Davey CC; Johnson MA; Emery VC; Griffiths PD
    AIDS; 2000 Jun; 14(9):1163-70. PubMed ID: 10894280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART).
    Dhillon B; Ramaesh K; Leen C
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():275-6. PubMed ID: 10624419
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of CMV retinitis in the era of highly active antiretroviral therapy.
    Jouan M; Katlama C
    Int J Antimicrob Agents; 1999 Sep; 13(1):1-7. PubMed ID: 10563398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMV after HAART.
    Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
    Deayton J; Mocroft A; Wilson P; Emery VC; Johnson MA; Griffiths PD
    AIDS; 1999 Jul; 13(10):1203-6. PubMed ID: 10416523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
    Kempen JH; Jabs DA; Dunn JP; West SK; Tonascia J
    Arch Ophthalmol; 2001 Jan; 119(1):33-40. PubMed ID: 11146724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK; Tonascia J
    Clin Infect Dis; 2003 Nov; 37(10):1365-73. PubMed ID: 14583871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S; Badelon I; Chaine G
    J Fr Ophtalmol; 1998 Jan; 21(1):34-41. PubMed ID: 9834898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and predictors of cytomegalovirus retinitis in HIV-infected patients with low CD4 lymphocyte counts in Vietnam.
    Colby DJ; Vo DQ; Teoh SC; Tam NT; Liem NT; Lu D; Nguyen TT; Cosimi L; Pollack T; Libman H
    Int J STD AIDS; 2014 Jun; 25(7):516-22. PubMed ID: 24327723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CMV retinitis and the controversies associated with highly active antiretroviral therapy and the immune recovery hypothesis.
    Reed JB; Morse LS
    AIDS Patient Care STDS; 1998 Mar; 12(3):181-5. PubMed ID: 11361932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment.
    Jalali S; Reed JB; Mizoguchi M; Flynn N; Gordon J; Morse LS
    AIDS Patient Care STDS; 2000 Jul; 14(7):343-6. PubMed ID: 10935050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristic and treatment of cytomegalovirus retinitis in 80 patients with acquired immunodeficiency syndrome].
    Yang Y; Jiang R; He T; Lu H; Zhang R; Shen Y; Zheng Y; Liu L; Wang W
    Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):197-202. PubMed ID: 24841816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HAART, CMV retinitis, and monitoring.
    De Smet MD
    Br J Ophthalmol; 2001 Jul; 85(7):766. PubMed ID: 11423442
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
    Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
    Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring cytomegalovirus retinitis prevalence in an HIV-seropositive cohort: the assessment of improvements observed following the introduction of highly active antiretroviral triple therapy.
    Hutchinson S; Courtney R; Mulcahy F; O'Connor M; Mullaney S; Kilbride R
    Int J STD AIDS; 1999 Oct; 10(10):652-6. PubMed ID: 10582631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.